{"schema_version":"secwatch.filing_event.v1","accession":"0001855747-25-000067","form_type":"8-K","ticker":"BLND","cik":"0001855747","company_name":"Blend Labs, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.393996+00:00","generated_at":"2026-05-17T18:20:40.973706+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"confidence":"high","headline":"Blend Q2 2025 revenue up 10% YoY to $31.5M; non-GAAP operating income positive","bullets":["GAAP loss from operations narrowed to $4.6M from $13.1M YoY; diluted EPS -$0.03 vs -$0.09.","Non-GAAP income from operations $4.7M (15% margin) vs loss of $5.5M in Q2 2024.","Record RPO of $190.4M; 23 new/expanded deals, more than double Q1 2025.","Sold Title365 to Covius to transition to a higher-margin partnership model.","Q3 guidance: revenue $31.5M-$33.5M, non-GAAP net operating income $3.0M-$4.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001855747-25-000067","json":"https://secwatch.observer/filing/0001855747-25-000067.json","markdown":"https://secwatch.observer/filing/0001855747-25-000067.md","text":"https://secwatch.observer/filing/0001855747-25-000067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855747/000185574725000067/0001855747-25-000067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855747/000185574725000067/blnd-20250807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:20:40.973706+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}